PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.\', \'Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.\', \'Department of Management Science and Engineering, Stanford University, Stanford, CA 94305, USA.\', \'DNARx, San Francisco, CA 94107, USA.\', \'Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.\', \'Los Altos High School, Los Altos, CA 94022, USA.\', \'Department of Bioengineering, Stanford University, Stanford, CA 94305, USA. Electronic address: mlarussa@stanford.edu.\', \'Department of Pediatrics, Stanford University, Stanford, CA 94305, USA. Electronic address: dblewis@stanford.edu.\', \'Department of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA; ChEM-H, Stanford University, Stanford, CA 94305, USA. Electronic address: stanley.qi@stanford.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0092-8674(20)30483-910.1016/j.cell.2020.04.020
?:doi
?:hasPublicationType
?:journal
  • Cell
is ?:pmid of
?:pmid
?:pmid
  • 32353252
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 25.137
?:rankingScore_hIndex
  • 682
is ?:relation_isRelatedTo_publication of
?:title
  • Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all